Esketamine Receives Support from 2 FDA Committees
Esketamine, a drug developed by Johnson & Johnson for the treatment of depression has received support from two FDA committees. Final FDA approval is expected by...
News at CenExel
Treatment Resistant Depression Clinical Trials Maryland
Treatment resistant depression clinical trials Maryland. We work with patients nationwide and in the Baltimore-Washington area.
Esketamine Clinical Trials 2019 Gaithersburg Washington DC Baltimore
Esketamine clinical trials 2019- we are currently offering paid clinical trials for esketamine and ketamine like compounds. Contact us to learn more.